Breakthrough research by Canadian Breast Cancer Foundation (BC/Yukon region) doctoral breast cancer research fellows Kristen Reipas and Dr Anna Stratford has been published in the journal Stem Cells.
Supported by Dr Sandra Dunn, UBC associate professor in the Faculty of Medicine, trainees Ms Reipas and Dr Stratford identified a protein critical to the survival of triple-negative breast cancer (TNBC) patients. This research has the potential to cure TNBC by targeting the protein RSK2, which eliminates TNBC cells completely. The study, published 5 June 2012, reports that RSK2 inhibitors have the ability to kill all of the cells including cancer stem cells which give rise to cancer recurrence.
The study abstract can be viewed here [8].
Links
[1] https://bcmj.org/cover/julyaugust-2012
[2] https://bcmj.org/node/4504
[3] https://bcmj.org/print/news/cbcf-research-potential-cure-tnbc
[4] https://bcmj.org/printmail/news/cbcf-research-potential-cure-tnbc
[5] http://www.facebook.com/share.php?u=https://bcmj.org/print/news/cbcf-research-potential-cure-tnbc
[6] https://twitter.com/intent/tweet?text=CBCF research: Potential cure for TNBC&url=https://bcmj.org/print/news/cbcf-research-potential-cure-tnbc&via=BCMedicalJrnl&tw_p=tweetbutton
[7] https://bcmj.org/javascript%3A%3B
[8] http://onlinelibrary.wiley.com/doi/10.1002/stem.1128/abstract
[9] https://bcmj.org/modal_forms/nojs/webform/176
[10] https://bcmj.org/%3Finline%3Dtrue%23citationpop